AVEO - AVEO Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue5,4097,5792,51519,024
Cost of Revenue20,65225,17923,70312,875
Gross Profit-15,243-17,600-21,1886,149
Operating Expenses
Research Development----
Selling General and Administrative10,7819,1388,20510,217
Non Recurring----
Others----
Total Operating Expenses31,43334,31731,90823,092
Operating Income or Loss-26,024-26,738-29,393-4,068
Income from Continuing Operations
Total Other Income/Expenses Net20,695-38,1862,607-10,933
Earnings Before Interest and Taxes-26,024-26,738-29,393-4,068
Interest Expense-2,191-2,373-1,949-2,286
Income Before Tax-5,329-64,924-26,786-15,001
Income Tax Expense-101101-
Minority Interest----
Net Income From Continuing Ops-5,329-65,025-26,887-15,001
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-5,329-65,025-26,887-15,001
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-5,329-65,025-26,887-15,001